Loading…

Aptamer based recognition of cancer cells: Recent progress and challenges in bioanalysis

Rapid and accurate monitoring of cancer cells with high sensitivity is essential for a successful cancer treatment. As high-affinity nucleic acid ligands, aptamers can improve the properties of detection methods by conjugating with intracellular or extracellular cancer biomarkers. Despite the advanc...

Full description

Saved in:
Bibliographic Details
Published in:Talanta (Oxford) 2020-12, Vol.220, p.121436-121436, Article 121436
Main Authors: Kordasht, Houman Kholafazad, Hasanzadeh, Mohammad
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c431t-b49cbef65d606e50379bbb5638affcf67acb4b2a175b636c05069b98047deb723
cites cdi_FETCH-LOGICAL-c431t-b49cbef65d606e50379bbb5638affcf67acb4b2a175b636c05069b98047deb723
container_end_page 121436
container_issue
container_start_page 121436
container_title Talanta (Oxford)
container_volume 220
creator Kordasht, Houman Kholafazad
Hasanzadeh, Mohammad
description Rapid and accurate monitoring of cancer cells with high sensitivity is essential for a successful cancer treatment. As high-affinity nucleic acid ligands, aptamers can improve the properties of detection methods by conjugating with intracellular or extracellular cancer biomarkers. Despite the advances in the early detection and treatment of cancer cells, lacking effective early detection tools is one of the causes of a high mortality rate. Aptasensors, which are based on the specificity of aptamer-target recognition, with transduction for analytical purposes have received particular attention due to their high sensitivity and selectivity, simple instrumentation, as well as low production cost. In this review, some selective and sensitive methods were summarized based on advanced nanomaterials towards aptasensing of cancer cells, such as blood, breast, cervical, colon, gastric, liver, and lung cancer cells. This review summarizes advances from 2010 to June 2020 in the development of aptasensors for cancer cell detection. Various aptasensing strategies are assessed according to their potential for reaching relevant limits of sensitivity, specificity, and degrees of multiplexing. Furthermore, we address the remaining challenges and opportunities to integrate aptasensing platforms into point-of-care solutions. Finally, the advantages and limitations of aptamer-based aptasensing strategies were reviewed. [Display omitted] •Aptamers have attracted considerable attention for biosensing of cancer cells due to their privileged potentials.•The importance of aptasensors and their application in specific monitoring of various cancer cells were discussed.•Application of aptasensors for biomedical analysis and early stage diagnosis of cancer were investigated.
doi_str_mv 10.1016/j.talanta.2020.121436
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2442842067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S003991402030727X</els_id><sourcerecordid>2442842067</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-b49cbef65d606e50379bbb5638affcf67acb4b2a175b636c05069b98047deb723</originalsourceid><addsrcrecordid>eNqFkFtLxDAQhYMoul5-gpJHX7pOLk1bX0TEGwiCKPgWknS6Zumma9IV_Pdm2dVXnwZmzsw58xFyymDKgKmL-XQ0vQmjmXLguceZFGqHTFhdiUKUldglEwDRFA2TcEAOU5oDABcg9smB4A2vpagn5P16OZoFRmpNwpZGdMMs-NEPgQ4ddSa4PHPY9-mSvqDDMNJlHGYRU6ImtNR9mL7HMMNEfaDWDyaY_jv5dEz2OtMnPNnWI_J2d_t681A8Pd8_3lw_FU4KNhZWNs5ip8pWgcISRNVYa0slatN1rlOVcVZablhVWiWUgxJUY5saZNWirbg4IuebuznW5wrTqBc-rQObgMMqaS5lfpWDqrK03EhdHFKK2Oll9AsTvzUDvYaq53oLVa-h6g3UvHe2tVjZBbZ_W78Us-BqI8D86JfHqJPzmNG1PgMddTv4fyx-AFNxi2k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2442842067</pqid></control><display><type>article</type><title>Aptamer based recognition of cancer cells: Recent progress and challenges in bioanalysis</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Kordasht, Houman Kholafazad ; Hasanzadeh, Mohammad</creator><creatorcontrib>Kordasht, Houman Kholafazad ; Hasanzadeh, Mohammad</creatorcontrib><description>Rapid and accurate monitoring of cancer cells with high sensitivity is essential for a successful cancer treatment. As high-affinity nucleic acid ligands, aptamers can improve the properties of detection methods by conjugating with intracellular or extracellular cancer biomarkers. Despite the advances in the early detection and treatment of cancer cells, lacking effective early detection tools is one of the causes of a high mortality rate. Aptasensors, which are based on the specificity of aptamer-target recognition, with transduction for analytical purposes have received particular attention due to their high sensitivity and selectivity, simple instrumentation, as well as low production cost. In this review, some selective and sensitive methods were summarized based on advanced nanomaterials towards aptasensing of cancer cells, such as blood, breast, cervical, colon, gastric, liver, and lung cancer cells. This review summarizes advances from 2010 to June 2020 in the development of aptasensors for cancer cell detection. Various aptasensing strategies are assessed according to their potential for reaching relevant limits of sensitivity, specificity, and degrees of multiplexing. Furthermore, we address the remaining challenges and opportunities to integrate aptasensing platforms into point-of-care solutions. Finally, the advantages and limitations of aptamer-based aptasensing strategies were reviewed. [Display omitted] •Aptamers have attracted considerable attention for biosensing of cancer cells due to their privileged potentials.•The importance of aptasensors and their application in specific monitoring of various cancer cells were discussed.•Application of aptasensors for biomedical analysis and early stage diagnosis of cancer were investigated.</description><identifier>ISSN: 0039-9140</identifier><identifier>EISSN: 1873-3573</identifier><identifier>DOI: 10.1016/j.talanta.2020.121436</identifier><identifier>PMID: 32928438</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Advanced nanomaterial ; Aptamer ; Aptamers, Nucleotide ; Biomedical analysis ; Biosensing Techniques ; Biotechnology ; Ligands ; Nanostructures ; Neoplasms - diagnosis ; Sensing</subject><ispartof>Talanta (Oxford), 2020-12, Vol.220, p.121436-121436, Article 121436</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-b49cbef65d606e50379bbb5638affcf67acb4b2a175b636c05069b98047deb723</citedby><cites>FETCH-LOGICAL-c431t-b49cbef65d606e50379bbb5638affcf67acb4b2a175b636c05069b98047deb723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32928438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kordasht, Houman Kholafazad</creatorcontrib><creatorcontrib>Hasanzadeh, Mohammad</creatorcontrib><title>Aptamer based recognition of cancer cells: Recent progress and challenges in bioanalysis</title><title>Talanta (Oxford)</title><addtitle>Talanta</addtitle><description>Rapid and accurate monitoring of cancer cells with high sensitivity is essential for a successful cancer treatment. As high-affinity nucleic acid ligands, aptamers can improve the properties of detection methods by conjugating with intracellular or extracellular cancer biomarkers. Despite the advances in the early detection and treatment of cancer cells, lacking effective early detection tools is one of the causes of a high mortality rate. Aptasensors, which are based on the specificity of aptamer-target recognition, with transduction for analytical purposes have received particular attention due to their high sensitivity and selectivity, simple instrumentation, as well as low production cost. In this review, some selective and sensitive methods were summarized based on advanced nanomaterials towards aptasensing of cancer cells, such as blood, breast, cervical, colon, gastric, liver, and lung cancer cells. This review summarizes advances from 2010 to June 2020 in the development of aptasensors for cancer cell detection. Various aptasensing strategies are assessed according to their potential for reaching relevant limits of sensitivity, specificity, and degrees of multiplexing. Furthermore, we address the remaining challenges and opportunities to integrate aptasensing platforms into point-of-care solutions. Finally, the advantages and limitations of aptamer-based aptasensing strategies were reviewed. [Display omitted] •Aptamers have attracted considerable attention for biosensing of cancer cells due to their privileged potentials.•The importance of aptasensors and their application in specific monitoring of various cancer cells were discussed.•Application of aptasensors for biomedical analysis and early stage diagnosis of cancer were investigated.</description><subject>Advanced nanomaterial</subject><subject>Aptamer</subject><subject>Aptamers, Nucleotide</subject><subject>Biomedical analysis</subject><subject>Biosensing Techniques</subject><subject>Biotechnology</subject><subject>Ligands</subject><subject>Nanostructures</subject><subject>Neoplasms - diagnosis</subject><subject>Sensing</subject><issn>0039-9140</issn><issn>1873-3573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkFtLxDAQhYMoul5-gpJHX7pOLk1bX0TEGwiCKPgWknS6Zumma9IV_Pdm2dVXnwZmzsw58xFyymDKgKmL-XQ0vQmjmXLguceZFGqHTFhdiUKUldglEwDRFA2TcEAOU5oDABcg9smB4A2vpagn5P16OZoFRmpNwpZGdMMs-NEPgQ4ddSa4PHPY9-mSvqDDMNJlHGYRU6ImtNR9mL7HMMNEfaDWDyaY_jv5dEz2OtMnPNnWI_J2d_t681A8Pd8_3lw_FU4KNhZWNs5ip8pWgcISRNVYa0slatN1rlOVcVZablhVWiWUgxJUY5saZNWirbg4IuebuznW5wrTqBc-rQObgMMqaS5lfpWDqrK03EhdHFKK2Oll9AsTvzUDvYaq53oLVa-h6g3UvHe2tVjZBbZ_W78Us-BqI8D86JfHqJPzmNG1PgMddTv4fyx-AFNxi2k</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Kordasht, Houman Kholafazad</creator><creator>Hasanzadeh, Mohammad</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20201201</creationdate><title>Aptamer based recognition of cancer cells: Recent progress and challenges in bioanalysis</title><author>Kordasht, Houman Kholafazad ; Hasanzadeh, Mohammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-b49cbef65d606e50379bbb5638affcf67acb4b2a175b636c05069b98047deb723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Advanced nanomaterial</topic><topic>Aptamer</topic><topic>Aptamers, Nucleotide</topic><topic>Biomedical analysis</topic><topic>Biosensing Techniques</topic><topic>Biotechnology</topic><topic>Ligands</topic><topic>Nanostructures</topic><topic>Neoplasms - diagnosis</topic><topic>Sensing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kordasht, Houman Kholafazad</creatorcontrib><creatorcontrib>Hasanzadeh, Mohammad</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Talanta (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kordasht, Houman Kholafazad</au><au>Hasanzadeh, Mohammad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aptamer based recognition of cancer cells: Recent progress and challenges in bioanalysis</atitle><jtitle>Talanta (Oxford)</jtitle><addtitle>Talanta</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>220</volume><spage>121436</spage><epage>121436</epage><pages>121436-121436</pages><artnum>121436</artnum><issn>0039-9140</issn><eissn>1873-3573</eissn><abstract>Rapid and accurate monitoring of cancer cells with high sensitivity is essential for a successful cancer treatment. As high-affinity nucleic acid ligands, aptamers can improve the properties of detection methods by conjugating with intracellular or extracellular cancer biomarkers. Despite the advances in the early detection and treatment of cancer cells, lacking effective early detection tools is one of the causes of a high mortality rate. Aptasensors, which are based on the specificity of aptamer-target recognition, with transduction for analytical purposes have received particular attention due to their high sensitivity and selectivity, simple instrumentation, as well as low production cost. In this review, some selective and sensitive methods were summarized based on advanced nanomaterials towards aptasensing of cancer cells, such as blood, breast, cervical, colon, gastric, liver, and lung cancer cells. This review summarizes advances from 2010 to June 2020 in the development of aptasensors for cancer cell detection. Various aptasensing strategies are assessed according to their potential for reaching relevant limits of sensitivity, specificity, and degrees of multiplexing. Furthermore, we address the remaining challenges and opportunities to integrate aptasensing platforms into point-of-care solutions. Finally, the advantages and limitations of aptamer-based aptasensing strategies were reviewed. [Display omitted] •Aptamers have attracted considerable attention for biosensing of cancer cells due to their privileged potentials.•The importance of aptasensors and their application in specific monitoring of various cancer cells were discussed.•Application of aptasensors for biomedical analysis and early stage diagnosis of cancer were investigated.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32928438</pmid><doi>10.1016/j.talanta.2020.121436</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0039-9140
ispartof Talanta (Oxford), 2020-12, Vol.220, p.121436-121436, Article 121436
issn 0039-9140
1873-3573
language eng
recordid cdi_proquest_miscellaneous_2442842067
source ScienceDirect Freedom Collection 2022-2024
subjects Advanced nanomaterial
Aptamer
Aptamers, Nucleotide
Biomedical analysis
Biosensing Techniques
Biotechnology
Ligands
Nanostructures
Neoplasms - diagnosis
Sensing
title Aptamer based recognition of cancer cells: Recent progress and challenges in bioanalysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T19%3A41%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aptamer%20based%20recognition%20of%20cancer%20cells:%20Recent%20progress%20and%20challenges%20in%20bioanalysis&rft.jtitle=Talanta%20(Oxford)&rft.au=Kordasht,%20Houman%20Kholafazad&rft.date=2020-12-01&rft.volume=220&rft.spage=121436&rft.epage=121436&rft.pages=121436-121436&rft.artnum=121436&rft.issn=0039-9140&rft.eissn=1873-3573&rft_id=info:doi/10.1016/j.talanta.2020.121436&rft_dat=%3Cproquest_cross%3E2442842067%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c431t-b49cbef65d606e50379bbb5638affcf67acb4b2a175b636c05069b98047deb723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2442842067&rft_id=info:pmid/32928438&rfr_iscdi=true